Hosted on MSN

Alpha Tau expands Alpha DaRT into recurrent prostate cancer: What investors should watch

Alpha Tau Medical Ltd (DRTS) announced an update on their ongoing clinical study. Study Overview – Alpha Tau Medical Ltd. (NASDAQ: DRTS) is launching a new safety study titled “A Safety Study of ...
Cleveland.com

Brain tumor breakthrough: First patient receives Alpha DaRT radiation at OSU

CLEVELAND, Ohio — The Ohio State University’s James Cancer Hospital has treated the world’s first brain cancer patient to receive a new radiation technology that attacks tumors from within, the ...